{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:27:21Z","timestamp":1773386841240,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A Hepatitis C (HCV) e-Consult Direct-To-Treatment (DTT) program managed by midlevel providers was developed at the Veteran Affairs Greater Los Angeles Healthcare System (VAGLAHS) which provided remote referral and, in some, remote management of HCV. DTT patients were more likely to be initiated on HCV treatment compared to standard of care (SOC), lending support for similar programs of remote engagement in HCV care.<\/jats:p>","DOI":"10.1038\/s41598-023-43052-7","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T16:02:12Z","timestamp":1697040132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of and implications for a novel hepatitis C e-consult direct-to-treatment pilot program"],"prefix":"10.1038","volume":"13","author":[{"given":"Neaka Z.","family":"Mohtashemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal Y.","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihane","family":"Benhammou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew Bidwell","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debika","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"43052_CR1","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.30297","volume":"69","author":"MG Hofmeister","year":"2019","unstructured":"Hofmeister, M. G. et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016. Hepatology (Baltimore, MD) 69, 1020\u20131031. https:\/\/doi.org\/10.1002\/hep.30297 (2019).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"43052_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/hep.20502","volume":"41","author":"JA Dominitz","year":"2005","unstructured":"Dominitz, J. A. et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology (Baltimore, MD) 41, 88\u201396. https:\/\/doi.org\/10.1002\/hep.20502 (2005).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"43052_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","volume":"62","author":"C Hepatitis","year":"2015","unstructured":"Hepatitis, C. guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology (Baltimore, MD) 62, 932\u2013954. https:\/\/doi.org\/10.1002\/hep.27950 (2015).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"43052_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cld.1150","volume":"18","author":"R Gonzalez","year":"2021","unstructured":"Gonzalez, R. et al. HCV elimination in the US Department of Veterans Affairs. Clin. Liver Dis. 18, 1\u20136. https:\/\/doi.org\/10.1002\/cld.1150 (2021).","journal-title":"Clin. Liver Dis."},{"key":"43052_CR5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1186\/s12913-021-07312-4","volume":"21","author":"V Yakovchenko","year":"2021","unstructured":"Yakovchenko, V. et al. Mapping the road to elimination: A 5-year evaluation of implementation strategies associated with hepatitis C treatment in the veterans health administration. BMC Health Serv. Res. 21, 1348. https:\/\/doi.org\/10.1186\/s12913-021-07312-4 (2021).","journal-title":"BMC Health Serv. Res."},{"key":"43052_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/m17-1073","volume":"167","author":"PS Belperio","year":"2017","unstructured":"Belperio, P. S., Chartier, M., Ross, D. B., Alaigh, P. & Shulkin, D. Curing hepatitis C virus infection: Best practices from the U.S. Department of Veterans Affairs. Ann. Intern. Med. 167, 499\u2013504. https:\/\/doi.org\/10.7326\/m17-1073 (2017).","journal-title":"Ann. Intern. Med."},{"key":"43052_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cld.1188","volume":"19","author":"K Hoyt","year":"2022","unstructured":"Hoyt, K. & Reynolds, A. The patient perspective on telemedicine. Clin. Liver Dis. 19, 167\u2013170. https:\/\/doi.org\/10.1002\/cld.1188 (2022).","journal-title":"Clin. Liver Dis."},{"key":"43052_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.amepre.2021.03.011","volume":"61","author":"HW Kaufman","year":"2021","unstructured":"Kaufman, H. W. et al. Decreases in hepatitis C testing and treatment during the COVID-19 pandemic. Am. J. Prev. Med. 61, 369\u2013376. https:\/\/doi.org\/10.1016\/j.amepre.2021.03.011 (2021).","journal-title":"Am. J. Prev. Med."},{"key":"43052_CR9","doi-asserted-by":"publisher","first-page":"103247","DOI":"10.1016\/j.drugpo.2021.103247","volume":"96","author":"A Amoako","year":"2021","unstructured":"Amoako, A., Ortiz-Paredes, D., Engler, K., Lebouch\u00e9, B. & Klein, M. B. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. Int. J. Drug Policy 96, 103247. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103247 (2021).","journal-title":"Int. J. Drug Policy"},{"issue":"Suppl 1","key":"43052_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1478-3231.2011.02706.x","volume":"32","author":"CE McGowan","year":"2012","unstructured":"McGowan, C. E. & Fried, M. W. Barriers to hepatitis C treatment. Liver Int. 32(Suppl 1), 151\u2013156. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02706.x (2012).","journal-title":"Liver Int."},{"key":"43052_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","volume":"20","author":"JA Morrill","year":"2005","unstructured":"Morrill, J. A., Shrestha, M. & Grant, R. W. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J. Gen. Intern. Med. 20, 754\u2013758. https:\/\/doi.org\/10.1111\/j.1525-1497.2005.0161.x (2005).","journal-title":"J. Gen. Intern. Med."},{"key":"43052_CR12","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/jvh.13746","volume":"29","author":"L Hartl","year":"2022","unstructured":"Hartl, L. et al. HCV hotline facilitates hepatitis C elimination during the COVID-19 pandemic. J. Viral Hepatitis 29, 1062\u20131072. https:\/\/doi.org\/10.1111\/jvh.13746 (2022).","journal-title":"J. Viral Hepatitis"},{"key":"43052_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/1357633x19885750","volume":"27","author":"L Case","year":"2021","unstructured":"Case, L., Wright, J. & Ryan, Y. Comparison of hepatitis C treatment outcomes between telehepatology and specialty care clinics in the era of direct-acting antivirals. J. Telemed. Telecare 27, 463\u2013468. https:\/\/doi.org\/10.1177\/1357633x19885750 (2021).","journal-title":"J. Telemed. Telecare"},{"key":"43052_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/phh.0000000000001061","author":"D Stephens","year":"2019","unstructured":"Stephens, D. et al. An evaluation of hepatitis C virus telehealth services serving tribal communities: Patterns of usage, evolving needs, and barriers. J. Public Health Manag. Pract. JPHMP https:\/\/doi.org\/10.1097\/phh.0000000000001061 (2019).","journal-title":"J. Public Health Manag. Pract. JPHMP"},{"key":"43052_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/jvh.13392","volume":"28","author":"TA Syed","year":"2021","unstructured":"Syed, T. A., Cherian, R., Lewis, S. & Sterling, R. K. Telemedicine HCV treatment in department of corrections results in high SVR in era of direct-acting antivirals. J. Viral Hepatitis 28, 209\u2013212. https:\/\/doi.org\/10.1111\/jvh.13392 (2021).","journal-title":"J. Viral Hepatitis"},{"key":"43052_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.amjmed.2016.11.019","volume":"130","author":"LA Beste","year":"2017","unstructured":"Beste, L. A. et al. Telemedicine specialty support promotes hepatitis C treatment by primary care providers in the Department of Veterans Affairs. Am. J. Med. 130, 432\u20138.e3. https:\/\/doi.org\/10.1016\/j.amjmed.2016.11.019 (2017).","journal-title":"Am. J. Med."},{"key":"43052_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.5604\/01.3001.0010.5277","volume":"16","author":"CL Cooper","year":"2017","unstructured":"Cooper, C. L. et al. Direct-acting antiviral therapy outcomes in Canadian chronic hepatitis C telemedicine patients. Ann. Hepatol. 16, 874\u2013880. https:\/\/doi.org\/10.5604\/01.3001.0010.5277 (2017).","journal-title":"Ann. Hepatol."},{"key":"43052_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060800","author":"V Rosato","year":"2022","unstructured":"Rosato, V. et al. Telemedicine improves HCV elimination among Italian People who use drugs: An innovative therapeutic model to increase the adherence to treatment into addiction care centers evaluated before and during the COVID-19 pandemic. Biology https:\/\/doi.org\/10.3390\/biology11060800 (2022).","journal-title":"Biology"},{"key":"43052_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/ciy899","volume":"69","author":"AH Talal","year":"2018","unstructured":"Talal, A. H. et al. Integrated, co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone. Clin. Infect. Dis. 69, 323\u2013331. https:\/\/doi.org\/10.1093\/cid\/ciy899 (2018).","journal-title":"Clin. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43052-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T12:25:18Z","timestamp":1700310318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43052-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43052"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-43052-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17241"}}